Advertisement

Molecular and Cellular Biochemistry

, Volume 281, Issue 1–2, pp 197–209 | Cite as

Safety and whole-body antioxidant potential of a novel anthocyanin-rich formulation of edible berries

  • Debasis Bagchi
  • Sashwati Roy
  • Viren Patel
  • Guanglong He
  • Savita Khanna
  • Navdeep Ojha
  • Christina Phillips
  • Sumona Ghosh
  • Manashi Bagchi
  • Chandan K. Sen
Article

Abstract

Edible berry extracts rich in anthocyanins possess a broad spectrum of therapeutic, pharmacologic and anti-carcinogenic properties. Six berry extracts (wild blueberry, bilberry, cranberry, elderberry, raspberry seeds and strawberry), singly and in combination, were studied in our laboratories for antioxidant efficacy, cytotoxic potential, cellular uptake and anti-angiogenic properties. Combinations of edible berry extracts were evaluated to develop a synergistic formula, OptiBerry, which exhibited high oxygen radical absorbance capacity (ORAC) value, low cytotoxicity and superior anti-angiogenic properties compared to the other combinations tested. The current study sought to determine the broad spectrum safety and antioxidant potential of OptiBerry in vivo. Acute oral LD50 of OptiBerry was greater than 5 g/kg in rats. Acute dermal LD50 of OptiBerry was greater than 2 g/kg. No changes in the body weight or adverse effects were observed following necropsy. Primary skin and eye irritation studies were conducted in New Zealand albino rabbits. OptiBerry was classified as slightly irritating to the skin (primary skin irritation index 0.3) and minimally irritating to the eye (maximum mean total score 6.0). The antioxidant potential of OptiBerry was investigated in rats and mice by assessing GSH redox status in tissues as well as by a unique state-of-the-art electron paramagnetic resonance (EPR) imaging of whole-body redox status. A clinically relevant hyperbaric oxygen (HBO) exposure system (2 atm, 2 h) was employed to study the antioxidant properties of OptiBerry. OptiBerry feeding (8 weeks) significantly prevented HBO-induced GSH oxidation in the lung and liver of vitamin E-deficient Sprague Dawley rats. Furthermore, OptiBerry-fed mice, when exposed to HBO, demonstrated significant protection in whole-body HBO-induced oxidation compared to the unfed controls by EPR imaging. Taken together, these results indicate that OptiBerry is reasonably safe and possess antioxidant properties.

Keywords

berry anthocyanins glutathione hyperbaric oxygen in vivo OptiBerry oxidative stress safety studies 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ofek I, Goldhar J, Zafriri D, Lis H, Adar R, Sharon N: Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. New Engl J Med 324: 1599, 1991PubMedGoogle Scholar
  2. 2.
    Colic M, Pavelic K: Molecular mechanisms of anticancer activity of natural dietetic products. J Mol Med 78: 333–336, 2000CrossRefPubMedGoogle Scholar
  3. 3.
    Kresty LA, Morse MA, Morgan C, Carlton PS, Lu L, Gupta A, Blackwood M, Stoner GD: Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res 61: 6112–6119, 2001PubMedGoogle Scholar
  4. 4.
    McCarty MF: Current prospects for controlling cancer growth with non-cytotoxic agents – nutrients, phytochemicals, herbal extracts, and available drugs. Med Hypotheses 56: 137–154, 2001PubMedGoogle Scholar
  5. 5.
    She QB, Bode AM, Ma WY, Chen NY, Dong Z: Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 61: 1604–1610, 2001PubMedGoogle Scholar
  6. 6.
    Xue H, Aziz RM, Sun N, Cassady JM, Kamendulis LM, Xu Y, Stoner GD, Klaunig JE: Inhibition of cellular transformation by berry extracts. [erratum appears in Carcinogenesis 22 (2001) 831–833]; Carcinogenesis 22: 351–356, 2001Google Scholar
  7. 7.
    Cao G, Prior RL: Anthocyanins are detected in human plasma after oral administration of an elderberry extract. Clin Chem 45: 574–576, 1999PubMedGoogle Scholar
  8. 8.
    Giavazzi R, Taraboletti G: Angiogenesis and angiogenesis inhibitors in cancer. Forum 9: 261–272, 1999PubMedGoogle Scholar
  9. 9.
    Griffioen AW, Molema G: Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52: 237–268, 2000PubMedGoogle Scholar
  10. 10.
    Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R, Schweigerer L: Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 57: 2916–2921, 1997PubMedGoogle Scholar
  11. 11.
    Fotsis T, Pepper MS, Montesano R, Aktas E, Breit S, Schweigerer L, Rasku S, Wahala K, Adlercreutz H: Phytoestrogens and inhibition of angiogenesis. Baillieres Clin Endocrinol Metabol 12: 649–666, 1998Google Scholar
  12. 12.
    Hayashi A, Gillen AC, Lott JR: Effects of daily oral administration of quercetin chalcone and modified citrus pectin. Altern Med Rev 5: 546–552, 2000PubMedGoogle Scholar
  13. 13.
    Hisa T, Kimura Y, Takada K, Suzuki F, Takigawa M: Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro. Anticancer Res 18: 783–790, 1998PubMedGoogle Scholar
  14. 14.
    Jiang C, Agarwal R, Lu J: Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: Inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells. Biochem Biophys Res Commun 276: 371–378, 2000CrossRefPubMedGoogle Scholar
  15. 15.
    Paper DH: Natural products as angiogenesis inhibitors. Planta Medica 64: 686–695, 1998PubMedGoogle Scholar
  16. 16.
    Roy S, Khanna S, Alessio HM, Vider J, Bagchi D, Bagchi M, Sen CK: Anti-angiogenic property of edible berries. Free Radic Res 36: 1023–1031, 2002CrossRefPubMedGoogle Scholar
  17. 17.
    Gordillo G, Onat D, Stockinger M, Roy S, Atalay M, Beck F, Sen C: A key angiogenic role of monocyte chemoattractant protein-1 in hemangioendothelioma proliferation. Am J Physiol Cell Physiol 287: C866–C873, 2004CrossRefPubMedGoogle Scholar
  18. 18.
    Gordillo GM, Atalay M, Roy S, Sen CK: Hemangioma model for in vivo angiogenesis: inducible oxidative stress and MCP-1 expression in EOMA cells. Methods Enzymol 352: 422–432, 2002PubMedGoogle Scholar
  19. 19.
    Atalay M, Gordillo G, Roy S, Rovin B, Bagchi D, Bagchi M, Sen CK: Anti-angiogenic property of edible berry in a model of hemangioma. FEBS Lett 544: 252–257, 2003CrossRefPubMedGoogle Scholar
  20. 20.
    Knight J: Safety concerns prompt US ban on dietary supplement. Nature 427: 90, 2004PubMedGoogle Scholar
  21. 21.
    Kahkonen MP, Hopia AI, Heinonen M: Berry phenolics and their antioxidant activity. J Agric Food Chem 49: 4076–4082, 2001CrossRefPubMedGoogle Scholar
  22. 22.
    Speit G, Dennog C, Radermacher P, Rothfuss A: Genotoxicity of hyperbaric oxygen. Mutation Res 512: 111–119, 2002PubMedGoogle Scholar
  23. 23.
    Draize J, Woodward G, Calvary H: Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 82: 377–390, 1944Google Scholar
  24. 24.
    Draize J: The appraisal of the safety of chemicals in foods. In: Drugs and Cosmetics. Dermal Toxicity, Association of Food and Drug Officials of the US, Topeka, KA, 1965, pp 46–59Google Scholar
  25. 25.
    Kay J, Calandra J: Interpretation of eye irritation tests. J Soc Cos Chem 13: 281–289, 1962Google Scholar
  26. 26.
    Sen CK, Khanna S, Babior BM, Hunt TK, Ellison EC, Roy S: Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J Biol Chem 277: 33284–33290, 2002CrossRefPubMedGoogle Scholar
  27. 27.
    Roy S, Venojarvi M, Khanna S, Sen CK: Simultaneous detection of tocopherols and tocotrienols in biological samples using HPLC-coulometric electrode array. Methods Enzymol 352: 326–332, 2002PubMedGoogle Scholar
  28. 28.
    Khanna S, Roy S, Ryu H, Bahadduri P, Swaan PW, Ratan RR, Sen CK: Molecular basis of vitamin E action: Tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem 278: 43508–43515, 2003CrossRefPubMedGoogle Scholar
  29. 29.
    He G, Shankar RA, Chzhan M, Samouilov A, Kuppusamy P, Zweier JL: Noninvasive instrument of anatomic structure and intraluminal oxygenation in the gastrointestinal tract of living mice with spatial and spectral EPR imaging. Proc Natl Acad Sci USA 96: 4586–4591, 1999PubMedGoogle Scholar
  30. 30.
    He G, Petryakov S, Samouilov A, Chzhan M, Kuppusamy P, Zweier J: Development of a resonator with automatic tuning and coupling capability to minimize sample motion noise for in vivo EPR spectroscopy. J Magn Reson 149: 218–227, 2001CrossRefPubMedGoogle Scholar
  31. 31.
    Sen CK, Khanna S, Gordillo G, Bagchi D, Bagchi M, Roy S: Oxygen, oxidants, and antioxidants in wound healing: An emerging paradigm. Ann NY Acad Sci 957: 239–249, 2002PubMedCrossRefGoogle Scholar
  32. 32.
    Gordillo GM, Sen CK: Revisiting the essential role of oxygen in wound healing. Am J Surg 186: 259–263, 2003CrossRefPubMedGoogle Scholar
  33. 33.
    Wu G, Fang YZ, Yang S, Lupton JR, Turner ND: Glutathione metabolism and its implications for health. J Nutr 134: 489–492, 2004PubMedGoogle Scholar
  34. 34.
    White CW, Mimmack RF, Repine JE: Accumulation of lung tissue oxidized glutathione (GSSG) as a marker of oxidant induced lung injury. Chest 89: 111S–113S, 1986PubMedGoogle Scholar
  35. 35.
    Jenkinson SG, Marcum RF, Pickard JS, Orzechowski Z, Lawrence RA, Jordan JM: Glutathione disulfide formation occurring during hypoxia and reoxygenation of rat lung. J Lab Clin Med 112: 471–480, 1988PubMedGoogle Scholar
  36. 36.
    Hammerschmidt S, Buchler N, Wahn H: Tissue lipid peroxidation and reduced glutathione depletion in hypochlorite-induced lung injury. Chest 121: 573–581, 2002CrossRefPubMedGoogle Scholar
  37. 37.
    Ookhtens M, Kaplowitz N: Role of the liver in interorgan homeostasis of glutathione and cyst(e)ine. Semin Liver Dis 18: 313–329, 1998PubMedCrossRefGoogle Scholar
  38. 38.
    Jaeschke H: Glutathione disulfide as index of oxidant stress in rat liver during hypoxia. Am J Physiol 258: G499–G505, 1990PubMedGoogle Scholar
  39. 39.
    Mandl J, Banhegyi G: Role of glutathione in the regulation of liver metabolism. Biofactors 17: 21–26, 2003PubMedGoogle Scholar
  40. 40.
    Yamauchi A, Tsuyuki S, Inamoto T, Yamaoka Y: Liver immunity and glutathione. Antioxid Redox Signal 1: 245–253, 1999PubMedGoogle Scholar
  41. 41.
    He G, Kumar Kutala V, Kuppusamy P, Zweier JL: In vivo measurement and mapping of skin redox stress induced by ultraviolet light exposure. Free Radic Biol Med 36: 665–672, 2004CrossRefPubMedGoogle Scholar
  42. 42.
    He G, Samouilov A, Kuppusamy P, Zweier JL: In vivo imaging of free radicals: applications from mouse to man. Mol Cell Biochem 234–235: 359–367, 2002Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  • Debasis Bagchi
    • 1
    • 2
    • 5
  • Sashwati Roy
    • 3
  • Viren Patel
    • 3
  • Guanglong He
    • 4
  • Savita Khanna
    • 3
  • Navdeep Ojha
    • 3
  • Christina Phillips
    • 3
  • Sumona Ghosh
    • 3
  • Manashi Bagchi
    • 2
  • Chandan K. Sen
    • 3
  1. 1.Department of Pharmacy Sciences, School of Pharmacy and Health ProfessionalsCreighton University Medical CenterOmaha
  2. 2.InterHealth Research CenterBenicia
  3. 3.Department of Surgery, Davis Heart and Lung Research InstituteThe Ohio State University Medical CenterColumbusUSA
  4. 4.Department of Medicine, Davis Heart and Lung Research InstituteThe Ohio State University Medical CenterColumbusUSA
  5. 5.Department of Pharmacy SciencesCreighton University Medical CenterOmahaUSA

Personalised recommendations